Plasma markers of COVID-19 severity: a pilot study

Plasma markers of COVID-19 severity: a pilot study

Abstract Background SARS-CoV-2 infected patients show heterogeneous clinical presentations ranging from mild symptoms to severe respiratory failure and death. Consequently, various markers reflect this wide spectrum of disease presentations. Methods Our pilot cohort included moderate (n = 10) and se...

Full description

Bibliographic Details
Main Authors: Julia Beimdiek, Sabina Janciauskiene, Sabine Wrenger, Sonja Volland, Adriana Rozy, Jan Fuge, Beata Olejnicka, Isabell Pink, Thomas Illig, Alexander Popov, Joanna Chorostowska, Falk F. R. Buettner, Tobias Welte
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Respiratory Research
Subjects:
COVID-9 severity
Acute phase proteins
Cell death
Inflammation
N-glycosylation
Trombosis
Online Access:https://doi.org/10.1186/s12931-022-02272-7

Internet

https://doi.org/10.1186/s12931-022-02272-7

Similar Items